MOSCOW (MRC) -- Arkema will be expanding its oleochemicals capacity by 50%, said the company.
New capacity for Arkema's bio-based portfolio is currently under construction on Jurong Island in Singapore, and scheduled to come onstream in mid-2022, complementing the company's existing production facilities in Marseille, France. Products set to be produced include C7, C11 and C18 materials, comprising n-heptanoic acid, n-heptaldehyde, undecylenic acid and esterol A.
These materials are used in a variety of markets including cosmetics, flavours and fragrances, lubricants, construction and pharmaceutical applications. Arkema is expanding capacity in line with growing demand for sustainable bio-based materials.
We are committed to driving sustainable castor bean farming and to expanding our global supply capability in concert with our customers,” said Arkema general manager for advanced bio-materials Philippe Marthet. "The expansion is completely consistent with our strategy to serve each region from within the region and its timing is welcomed by the market, which shows a strong demand for bio-based specialties."
As per MRC, Arkema is further increasing its fluoropolymer production capacities in Changshu, China, by 35% in 2022. The increase in capacity is scheduled to come on stream before the end of 2022, the company said in a statement. Financial and overall capacity details of the expansion project were not disclosed.
Trinseo completed the acquisition of Arkema's PMMA business for EUR1.14 billion. The EUR1.14 billion deal was announced in December and was expected to be completed by mid-2021. The company has seven PMMA plants, four in Europe and three in North America. Products are marketed under the Plexiglas brands in the Americas and Altuglas in the rest of the world.
Arkema is one of the world's leading chemical manufacturers headquartered in Colombes (near Paris, France). Founded in 2004 as a result of the restructuring of the French oil company Total, Arkema, with a turnover of EUR6.5 billion, has operations in 40 countries, 10 research centers around the world, and 85 factories in Europe, North America and Asia.
MRC